PPI-amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta-analysis

Helicobacter Pylori

PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis

Helicobacter.

Gao CP, Zhang D, Zhang T, Wang JX, Han SX, Graham DY, Lu H

doi: 10.1111/hel.12692.

Helicobacter Pylori

The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis

Helicobacter.

Zou Y, Qian X, Liu X, Song Y, Song C, Wu S, An Y, Yuan R, Wang Y, Xie Y

doi: 10.1111/hel.12714.

RECOMMENDED

Gastrointestinal CancerHelicobacter Pylori

Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis

★ 3 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

doi: 10.1136/gutjnl-2020-320839.

Helicobacter Pylori

Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta-analysis

Helicobacter.

Ye Q, Shao X, Shen R, Chen D, Shen J

doi: 10.1111/hel.12713.

Helicobacter Pylori

Once-daily rabeprazole, levofloxacin, clarithromycin-MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study)

Helicobacter.

Auttajaroon J, Vilaichone RK, Chotivitayatarakorn P, Mahachai V

doi: 10.1111/hel.12615.

Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions

Gastroenterology.

Savoldi A, Carrara E, Graham Prof DY, Conti M, Tacconelli E

doi: 10.1053/j.gastro.2018.07.007.

Esophagus DiseasesHelicobacter Pylori

Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-a Systematic Review and Meta-analysis

Clin Gastroenterol Hepatol.

Shah SC, Tepler A, Peek RM Jr, Colombel JF, Hirano I, Narula N

doi: 10.1016/j.cgh.2019.01.013.

Helicobacter Pylori

Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children

Helicobacter.

Zhou Y, Ye Z, Wang Y, Zhang Y, Tang Z, Yan W, Jiang Y, Huang Y

doi: 10.1111/hel.12679.

Helicobacter Pylori

N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication

Cochrane Database Syst Rev.

Fontes LES, Martimbianco ALC, Zanin C, Riera R

doi: 10.1002/14651858.

Related content

PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis

The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis

Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis

Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta-analysis

Once-daily rabeprazole, levofloxacin, clarithromycin-MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study)

Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions

Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-a Systematic Review and Meta-analysis

Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children

N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication